UPC Analytics
DEEN
Übersicht · Eingereicht: 14. Aug. 2024

UPC_CFI_486/2024

ENDOLUMINAL LASER ABLATION DEVICE FOR TREATING VEINS

Einstweilige MaßnahmenEinstweilige MaßnahmenDusseldorf LDProvisional measuresCase Closed
Zusammenfassung in einfacher Sprache

Bioletic Holding GmbH & Co. KG applied to the Düsseldorf Local Division for a preliminary injunction against Light Guide Optics Germany GmbH and S.I.A. LIGHTGUIDE International based on EP 3 685 783 B1 (endoluminal laser ablation device for vein treatment). The court rejected the application without oral hearing, finding that Bioletic had not specifically demonstrated why a main action would be insufficient to provide adequate legal protection; the evidence of harm (market saturation, distributor estimates, Italian tenders) was speculative and insufficient to establish the substantive necessity for provisional measures.

Angenommene Argumente
Was das Gericht akzeptiert hat — nach Partei.
  • Applicant failed to demonstrate why a main action would be insufficient to provide adequate legal protection, making provisional measures unnecessary

    BeklagterRechtsgrundlage: R. 206; R. 209.1-2 VerfO

    Hinweis: Court held that the substantive necessity of provisional measures requires a specific showing that the harm cannot be adequately compensated through a main action; mere invocation of urgency timeframes is insufficient.

  • Court may dismiss provisional measures application without oral hearing where applicant indicates no further oral discussion is needed if court maintains its preliminary view

    BeklagterRechtsgrundlage: R. 209.1-2 VerfO

    Hinweis: After the court signalled the application lacked merit, Bioletic indicated no further hearing was needed; the court exercised its discretion to dismiss without oral hearing.

Zurückgewiesene Argumente
Was das Gericht nicht akzeptiert hat — und warum.
  • Market saturation from infringing products and long-term customer lock-in create irreparable harm justifying provisional measures

    Kläger

    Begründung: Bioletic's evidence of market saturation (6–12 months) and customer lock-in was based on speculation and estimates of one distributor rather than concrete evidence; no specific harm was shown that could not be compensated monetarily in main proceedings.

  • Ongoing tenders in Italy creating long-term binding commitments justify urgent provisional measures

    Kläger

    Begründung: The reference to tenders was too generic and did not substantiate specific, concrete harm of the magnitude justifying provisional measures rather than a main action.